Antimicrobial peptides: New drugs for bad bugs?

Expert Opinion on Biological Therapy

Volumn 14, Issue 1, 2014, Pages 11-14

  Steckbeck, Jonathan D ^a,b   Deslouches, Berthony ^a,b   Montelaro, Ronald C ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotics; Antimicrobial peptides; Drug resistant bacteria; Peptide design

Indexed keywords

GRAMICIDIN; PEXIGANAN; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLONE DERIVATIVE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL CELL; BACTERIAL INFECTION; BACTERIAL STRAIN; DIABETIC FOOT; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MEMBRANE DAMAGE; PNEUMONIA; PROTEIN SECONDARY STRUCTURE; REVIEW;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; DRUG DESIGN; DRUG RESISTANCE, BACTERIAL; HUMANS;

EID: 84890143728     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2013.844227     Document Type: Review

References (22)

1. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-95
2. Wang G, Li X, Wang Z. APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res 2009;37:D933-7
3. Nguyen LT, Haney EF, Vogel HJ. The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol 2011;29:464-72
4. Fjell CD, Hiss JA, Hancock REW, Schneider G. Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 2012;11:37-51
5. Jenssen H, Hamill P, Hancock REW. Peptide antimicrobial agents. Clin Microbiol Rev 2006;19:491-511
6. Hale JDF, Hancock REW. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev Anti Infect Ther 2007;5:951-9
7. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 2005;3:238-50
8. Hancock REW, Nijnik A, Philpott DJ. Modulating immunity as a therapy for bacterial infections. Nat Rev Microbiol 2012;10:243-54
9. Cooper MA, Shlaes D. Fix the antibiotics pipeline. Nature 2011;472:32
10. Fox JL. Antimicrobial peptides stage a comeback. Nat Biotechnol 2013;31:379-82
11. Liu D, DeGrado WF. De novo design, synthesis, and characterization of antimicrobial beta-peptides. J Am Chem Soc 2001;123:7553-9
12. Deslouches B, Phadke SM, Lazarevic V, et al. De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrob Agents Chemother 2005;49:316-22
13. Loose C, Jensen K, Rigoutsos I, Stephanopoulos G. A linguistic model for the rational design of antimicrobial peptides. Nature 2006;443:867-9
14. Muhle SA, Tam JP. Design of Gram-negative selective antimicrobial peptides. Biochemistry 2001;40:5777-85
15. Deslouches B, Gonzalez IA, DeAlmeida D, et al. De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia. J Antimicrob Chemother 2007;60:669-72
16. Cherkasov A, Hilpert K, Jenssen H, et al. Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem Biol 2009;4:65-74
17. Deslouches B, Steckbeck JD, Craigo JK, et al. Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens. Antimicrob Agents Chemother 2013;57:2511-21
18. Peschel A, Sahl H-G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol 2006;4:529-36
19. Batoni G, Maisetta G, Brancatisano FL, et al. Use of antimicrobial peptides against microbial biofilms: Advantages and limits. Curr Med Chem 2011;18:256-279
20. la Fuente-Nunez de C, Korolik V, Bains M, et al. Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide. Antimicrob Agents Chemother 2012;56:2696-704
21. Peters BM, Shirtliff ME, Jabra-Rizk MA. Antimicrobial peptides: primeval molecules or future drugs? PLoS Pathog 2010;6:e1001067
22. Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 2007;6:29-40